Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Intrinsic Factor
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Intrinsic Factor

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A glycoprotein secreted by the cells of the gastric glands that is required for the absorption of vitamin B 12 (cyanocobalamin).

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (921 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A glycoprotein secreted by the cells of the gastric glands that is required for the absorption of vitamin B 12 (cyanocobalamin). Deficiency of intrinsic factor leads to vitamin B 12 deficiency and anemia, pernicious.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Factor, Intrinsic.

Where it fits in the MeSH classification

Broader topics
Mucoproteins

Related concepts

  • Gastric Mucosa
  • Vitamins
  • Deficiency
  • Anemia
  • Pernicious

Research landscape

PubMed indexes 1,905 records tagged with the MeSH heading “Intrinsic Factor” (counts retrieved 2026-10-31). 47 of them (2.5%) were published from 2020 onward, and the busiest period so far is through 1999 with 1,686 records.

Reviews account for 173 records (9.1%) and meta-analyses for 0. Randomized controlled trials number 5 (0.3%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,686 records; 2000-2009: 89 records; 2010-2019: 83 records; 2020 onward: 47 records1,686through 1999892000-2009832010-2019472020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,686
2000-200989
2010-201983
2020 onward47
Share of records by publication typeReviews: 9.1 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.3 percentReviews9.1% (173)Meta-analyses0.0% (0)Randomized controlled trials0.3% (5)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,905 PubMed records
TypeRecordsShare
Reviews1739.1%
Meta-analyses00.0%
Randomized controlled trials50.3%

Method: PubMed query "Intrinsic Factor"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns
Tanner SM, Sturm AC, Baack EC, Liyanarachchi S, de la Chapelle A
2012Research article
Design not recorded in structured metadata
41cc by
PMID 22929189 · DOI · PMC3462684
The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses
Wüstenhagen E, Boukhallouk F, Negwer I, Rajalingam K, Stubenrauch F, Florin L
2018Research article
Design not recorded in structured metadata
23cc by
PMID 30018400 · DOI · PMC6265261
Pten is a key intrinsic factor regulating raphe 5-HT neuronal plasticity and depressive behaviors in mice
Chen L, Gong WK, Yang CP, Shao CC, Song NN, Chen JY, et al.
2021Research article
Design not recorded in structured metadata
18cc by
PMID 33771970 · DOI · PMC7998026
Serum Concentrations of Gastric Intrinsic Factor-A Pilot Study on Patients Undergoing Bariatric Surgery, Presenting with Portal Hypertension, or Suspected Pernicious Anemia
Greibe E, Nexo E, Sahlertz SR, Kornerup LS
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42451073 · DOI · PMC13363420

Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns [1]

Research article Tanner SM, Sturm AC, Baack EC, Liyanarachchi S, de la Chapelle A · · 2012 · cited 41 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundInherited malabsorption of cobalamin (Cbl) causes hematological and neurological abnormalities that can be fatal.
Closing excerpt
This study provides the first comprehensive overview of the genetics that underlies the inherited Cbl malabsorption phenotype.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (320 words)

BackgroundInherited malabsorption of cobalamin (Cbl) causes hematological and neurological abnormalities that can be fatal. Three genes have been implicated in Cbl malabsorption; yet, only about 10% of ~400-500 reported cases have been molecularly studied to date. Recessive mutations in CUBN or AMN cause Imerslund-Gräsbeck Syndrome (IGS), while recessive mutations in GIF cause Intrinsic Factor Deficiency (IFD). IGS and IFD differ in that IGS usually presents with proteinuria, which is not observed in IFD. The genetic heterogeneity and numerous differential diagnoses make clinical assessment difficult.MethodsWe present a large genetic screening study of 154 families or patients with suspected hereditary Cbl malabsorption. Patients and their families have been accrued over a period spanning >12 years. Systematic genetic testing of the three genes CUBN, AMN, and GIF was accomplished using a combination of single strand conformation polymorphism and DNA and RNA sequencing. In addition, six genes that were contenders for a role in inherited Cbl malabsorption were studied in a subset of these patients.ResultsOur results revealed population-specific mutations, mutational hotspots, and functionally distinct regions in the three causal genes. We identified mutations in 126/154 unrelated cases (82%). Fifty-three of 126 cases (42%) were mutated in CUBN, 45/126 (36%) were mutated in AMN, and 28/126 (22%) had mutations in GIF. We found 26 undescribed mutations in CUBN, 19 in AMN, and 7 in GIF for a total of 52 novel defects described herein. We excluded six other candidate genes as culprits and concluded that additional genes might be involved.ConclusionsCbl malabsorption is found worldwide and genetically complex. However, our results indicate that population-specific founder mutations are quite common. Consequently, targeted genetic testing has become feasible if ethnic ancestry is considered. These results will facilitate clinical and molecular genetic testing of Cbl malabsorption. Early diagnosis improves the lifelong care required by these patients and prevents potential neurological long-term complications. This study provides the first comprehensive overview of the genetics that underlies the inherited Cbl malabsorption phenotype.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 22929189 · DOI · PMC3462684

The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses [2]

Research article Wüstenhagen E, Boukhallouk F, Negwer I, Rajalingam K, Stubenrauch F, Florin L · · 2018 · cited 23 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The skin represents a physical and chemical barrier against invading pathogens, which is additionally supported by restriction factors that provide intrinsic cellular immunity.
Closing excerpt
Moreover, overexpression of MYPOP blocks colony formation of HPV and non-virally transformed keratinocytes, suggesting that MYPOP exhibits tumor suppressor properties.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (190 words)

The skin represents a physical and chemical barrier against invading pathogens, which is additionally supported by restriction factors that provide intrinsic cellular immunity. These factors detect viruses to block their replication cycle. Here, we uncover the Myb-related transcription factor, partner of profilin (MYPOP) as a novel antiviral protein. It is highly expressed in the epithelium and binds to the minor capsid protein L2 and the DNA of human papillomaviruses (HPV), which are the primary causative agents of cervical cancer and other tumors. The early promoter activity and early gene expression of the oncogenic HPV types 16 and 18 is potently silenced by MYPOP. Cellular MYPOP-depletion relieves the restriction of HPV16 infection, demonstrating that MYPOP acts as a restriction factor. Interestingly, we found that MYPOP protein levels are significantly reduced in diverse HPV-transformed cell lines and in HPV-induced cervical cancer. Decades ago it became clear that the early oncoproteins E6 and E7 cooperate to immortalize keratinocytes by promoting degradation of tumor suppressor proteins. Our findings suggest that E7 stimulates MYPOP degradation. Moreover, overexpression of MYPOP blocks colony formation of HPV and non-virally transformed keratinocytes, suggesting that MYPOP exhibits tumor suppressor properties.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30018400 · DOI · PMC6265261

Pten is a key intrinsic factor regulating raphe 5-HT neuronal plasticity and depressive behaviors in mice [3]

Research article Chen L, Gong WK, Yang CP, Shao CC, Song NN, Chen JY, et al. · · 2021 · cited 18 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Serotonin (5-HT)-based antidepressants, selective serotonin reuptake inhibitors (SSRIs) aim to enhance serotonergic activity by blocking its reuptake.
Closing excerpt
Thus, PTEN is an intrinsic regulator of 5-HT neuron activity, representing a novel therapeutic strategy for producing antidepressant action.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (180 words)

Serotonin (5-HT)-based antidepressants, selective serotonin reuptake inhibitors (SSRIs) aim to enhance serotonergic activity by blocking its reuptake. We propose PTEN as a target for an alternative approach for regulating 5-HT neuron activity in the brain and depressive behaviors. We show that PTEN is elevated in central 5-HT neurons in the raphe nucleus by chronic stress in mice, and selective deletion of Pten in the 5-HT neurons induces its structural plasticity shown by increases of dendritic branching and density of PSD95-positive puncta in the dendrites. 5-HT levels are elevated and electrical stimulation of raphe neurons evokes more 5-HT release in the brain of condition knockout (cKO) mice with Pten-deficient 5-HT neurons. In addition, the 5-HT neurons remain normal electrophysiological properties but have increased excitatory synaptic inputs. Single-cell RNA sequencing revealed gene transcript alterations that may underlay morphological and functional changes in Pten-deficient 5-HT neurons. Finally, Pten cKO mice and wild-type mice treated with systemic application of PTEN inhibitor display reduced depression-like behaviors. Thus, PTEN is an intrinsic regulator of 5-HT neuron activity, representing a novel therapeutic strategy for producing antidepressant action.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 33771970 · DOI · PMC7998026

Serum Concentrations of Gastric Intrinsic Factor-A Pilot Study on Patients Undergoing Bariatric Surgery, Presenting with Portal Hypertension, or Suspected Pernicious Anemia [4]

Research article Greibe E, Nexo E, Sahlertz SR, Kornerup LS · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Background/Objectives: Small quantities of gastric parietal cell-derived Intrinsic Factor (IF) are present in circulation.
Closing excerpt
Future longitudinal studies are needed to illuminate possible usefulness for measurement of circulating IF.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (231 words)

Background/Objectives: Small quantities of gastric parietal cell-derived Intrinsic Factor (IF) are present in circulation. Here, we explore circulating concentrations of IF in different medical conditions affecting the stomach, anticipating finding both low and high concentrations depending on the state of the parietal cells. Methods: We measured serum IF in (I) patients before and after bariatric surgery; (II) patients diagnosed with portal hypertension; and (III) patients with suspected pernicious anemia referred for measurement of IF autoantibodies. Results: Patients undergoing bariatric surgery (n = 25) showed a significant drop in serum IF following surgery. Their median serum IF declined from 5.1 pmol/L (pre-surgery) to 3.3 pmol/L (two months post-surgery), and nine out of 25 patients showed serum IF concentrations below reference interval (1.7-11.6 pmol/L). Most patients with portal hypertension (n = 18) showed normal serum IF concentrations, but with unexpectedly high concentrations up to 30 pmol/L in a few patients. Out of 120 patients referred for measurement of IF autoantibodies, 10 patients showed IF concentrations below the reference interval. Three out of four patients with IF autoantibodies showed low concentrations of circulating IF. Conclusions: Our study shows a decline in circulating IF following bariatric surgery consistent with the known decline in vitamin B12 uptake in these patients. Both high and low concentrations were observed in the other two groups. Future longitudinal studies are needed to illuminate possible usefulness for measurement of circulating IF.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42451073 · DOI · PMC13363420

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Malabsorption of food cobalamin [5]
    Carmel R · Baillieres Clin Haematol · 1995 · cited 93 times (Europe PMC)
  • Research article IMMUNOLOGIC ASPECTS OF PERNICIOUS ANEMIA [6]
    IRVINE WJ · N Engl J Med · 1965 · cited 79 times (Europe PMC)
  • Research article Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract [7]
    Festen HP · Scand J Gastroenterol Suppl · 1991 · cited 49 times (Europe PMC)
  • Research article Cellular import of cobalamin (Vitamin B-12) [8]
    Seetharam B, Bose S, Li N · J Nutr · 1999 · cited 38 times (Europe PMC)
  • Research article Autoimmune Gastritis [9]
    Hall SN, Appelman HD · Arch Pathol Lab Med · 2019 · cited 34 times (Europe PMC)
  • Research article Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. a personal journey [10]
    Alpers DH, Russell-Jones G · Biochimie · 2013 · cited 31 times (Europe PMC)

References

  1. Tanner SM, Sturm AC, Baack EC, Liyanarachchi S, de la Chapelle A. Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns. . 2012. PMID 22929189 · DOI · PMC3462684
  2. Wüstenhagen E, Boukhallouk F, Negwer I, Rajalingam K, Stubenrauch F, Florin L. The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses. . 2018. PMID 30018400 · DOI · PMC6265261
  3. Chen L, Gong WK, Yang CP, Shao CC, Song NN, Chen JY, et al.. Pten is a key intrinsic factor regulating raphe 5-HT neuronal plasticity and depressive behaviors in mice. . 2021. PMID 33771970 · DOI · PMC7998026
  4. Greibe E, Nexo E, Sahlertz SR, Kornerup LS. Serum Concentrations of Gastric Intrinsic Factor-A Pilot Study on Patients Undergoing Bariatric Surgery, Presenting with Portal Hypertension, or Suspected Pernicious Anemia. . 2026. PMID 42451073 · DOI · PMC13363420
  5. Carmel R. Malabsorption of food cobalamin. Baillieres Clin Haematol. 1995. PMID 8534965 · DOI
  6. IRVINE WJ. IMMUNOLOGIC ASPECTS OF PERNICIOUS ANEMIA. N Engl J Med. 1965. PMID 14328108 · DOI
  7. Festen HP. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol Suppl. 1991. PMID 1775933 · DOI
  8. Seetharam B, Bose S, Li N. Cellular import of cobalamin (Vitamin B-12). J Nutr. 1999. PMID 10498744 · DOI
  9. Hall SN, Appelman HD. Autoimmune Gastritis. Arch Pathol Lab Med. 2019. PMID 31661309 · DOI
  10. Alpers DH, Russell-Jones G. Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. a personal journey. Biochimie. 2013. PMID 23274574 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Protein SDrugs and Chemicals
  • Macrophage Colony-Stimulating FactorDrugs and Chemicals
  • VitronectinDrugs and Chemicals
  • Granulocyte Colony-Stimulating FactorDrugs and Chemicals
  • Granulocyte-Macrophage Colony-Stimulating FactorDrugs and Chemicals
  • Colony-Stimulating FactorsDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

1,905
PubMed records on this heading
2%
published since 2020
173
review articles
5
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Protein SDrugs and Chemicals
  • Macrophage Colony-Stimulating FactorDrugs and Chemicals
  • VitronectinDrugs and Chemicals
  • Granulocyte Colony-Stimulating FactorDrugs and Chemicals
  • Granulocyte-Macrophage Colony-Stimulating FactorDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support